Evidence map›Paper›PMID 26412506›Full record

ArticleScientific reports2015

The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling.

Ryosuke Omori, Yukihiko Nakata, Heidi L Tessmer, Satowa Suzuki, Keigo Shibayama

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Trends and outcomes ofMicrobiology spectrum · 2026
    Article
  4. Neurological Manifestations ofOpen forum infectious diseases · 2026
    Article
  5. Complex multiannual cycles ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Observational
  7. Article
  8. Trends inMicrobiology spectrum · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Clinical characteristics and logistic regression analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  13. Article
  14. Increased incidence ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  15. Article
  16. Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  17. Molecular Tools for TypingFrontiers in microbiology · 2022
    Review
  18. Experimental and therapeutic medicine · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ryosuke OmoriDivision of Bioinformatics, Research Center for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.
Yukihiko NakataGraduate School of Mathematical Sciences, The University of Tokyo, Tokyo, 153-8914, Japan.
Heidi L TessmerDivision of Bioinformatics, Research Center for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.
Satowa SuzukiDepartment of Bacteriology II, National Institute of Infectious Diseases, Tokyo, 208-0011, Japan.
Keigo ShibayamaDepartment of Bacteriology II, National Institute of Infectious Diseases, Tokyo, 208-0011, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Until the early 1990 s, incidences of Mycoplasma pneumoniae (MP) infection showed three to five year epidemic cycles in multiple countries, however, the mechanism for the MP epidemic cycle has not been understood. Here, we investigate the determinant of periodicity in MP incidence by employing a mathematical model describing MP transmission dynamics. Three candidates for the determinant of periodicity were evaluated: school-term forcing, minor variance in the duration of immunity, and epidemiological interference between MP serotypes. We find that minor variation in the duration of immunity at the population level must be considered essential for the MP epidemic cycle because the MP cyclic incidence pattern did not replicate without it. Minor variation, in this case, is a less dispersed distribution for the duration of immunity than an exponential distribution. Various lengths of epidemic cycles, including cycles typically found in nature, e.g. three to five year cycles, were also observed when there was minor variance in the duration of immunity. The cyclic incidence pattern is robust even if there is epidemiological interference due to cross-immune protection, which is observed in the epidemiological data as negative correlation between epidemics per MP serotype.

Indexed as

Models, TheoreticalPeriodicityComputer SimulationHumansImmunityIncidenceJapanMycoplasma pneumoniaePneumonia, Mycoplasma

Identifiers

PMID26412506
PMCPMC4585982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.